EASI p-EASI: Predicting Disease Severity in Patients with Atopic Dermatitis Treated with Tralokinumab.

Autor: Olydam JI; Department of Dermatology, Erasmus University Medical Center, Rotterdam, The Netherlands., de Wijs LEM; Department of Dermatology, Erasmus University Medical Center, Rotterdam, The Netherlands., Dik WA; Laboratory Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands., Røpke MA; Department of Clinical Pharmacology, LEO Pharma A/S, Ballerup, Denmark., Da Rosa JC; Department of Biostatistics, The Rockefeller University Hospital, The Rockefeller University, New York, New York, USA., Hijnen DJ; Department of Dermatology, Erasmus University Medical Center, Rotterdam, The Netherlands. Electronic address: d.hijnen@erasmusmc.nl.
Jazyk: angličtina
Zdroj: The Journal of investigative dermatology [J Invest Dermatol] 2022 Dec; Vol. 142 (12), pp. 3335-3337.e1. Date of Electronic Publication: 2022 Jul 16.
DOI: 10.1016/j.jid.2022.06.008
Databáze: MEDLINE